Project details
- Project period
- 1 Oct 2024 - 31 Mar 2027
- Total cost
- €1 377 183,75
- Global Health EDCTP3 funding
- €1 371 783,75
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-Mpox
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Emerging or re-emerging infectious diseases
- Intervention type
- VaccinesDiagnostics
Consortium map
Coordinator
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
- Location
- DUBLIN, Ireland
- EU contribution
- €302 740,00
- Total cost
- €308 140,00
Beneficiaries
NATIONAL INSTITUTE FOR MEDICAL RESEARCH
- Location
- DAR ES SALAAM, Tanzania
- EU contribution
- €201 256,25
- Total cost
- €201 256,25
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
- Location
- ST ANDREWS, United Kingdom
- EU contribution
- €77 996,25
- Total cost
- €77 996,25
MAKERERE UNIVERSITY LUNG INSTITUTE
- Location
- KAMPALA, Uganda
- EU contribution
- €262 417,50
- Total cost
- €262 417,50
UGANDA NATIONAL HEALTH RESEARCH ORGANISATION
- Location
- Entebbe, Uganda
- EU contribution
- €311 425,00
- Total cost
- €311 425,00
UNIVERSITE CATHOLIQUE DE BUKAVU
- Location
- BUKAVU, Democratic Republic of the Congo
- EU contribution
- €215 948,75
- Total cost
- €215 948,75
Related projects
Supporting mpox responses and research in eastern DRCThe MBOTE-SK project is embedding research within the response to the new clade Ib mpox outbreak in eastern DRC.
Rapid protection against Ebola virusThe EBO-PEP project is evaluating whether monoclonal antibodies can protect close contacts of people with Ebola virus infections.
Pregnant women have an increased risk of severe mpox disease, however, the underlying mechanisms remain elusive. To better understand altered transmission pattern of MPXV and its impact on...